We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Plans and resources in readiness for radiological and nuclear emergencies that may have an impact on public health.
Guidance primarily aimed at local responders and developed in line with the Civil Contingencies Act (CCA) on recovering from an emergency in the UK.
Information on the reporting, investigation and management of acute flaccid paralysis (AFP) and acute flaccid myelitis (AFM).
All organisations are at some form of risk from the hazards of everyday living.
Government funding for innovation in smart energy systems and technologies
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Guidance for industry on preparing responses to good laboratory practice (GLP) and good clinical practice (GCP) inspection reports.
Using an ecological momentary assessment to evaluate your digital health product.
Providing vital research into COVID-19 immunity and vaccine effectiveness nationally.
Overview of the study of abiotic stress responses in a range of model, grain and forage legumes species
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Article in Journal of Experimental Botany
Helping public health practitioners conducting evaluations – choosing evaluation methods.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.